Abiomed, Inc.ABMDNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-2.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2022 | -87.26% |
| Q2 2022 | -4.31% |
| Q1 2022 | -23.72% |
| Q4 2021 | 57.47% |
| Q3 2021 | 10.71% |
| Q2 2021 | -20.17% |
| Q1 2021 | -15.47% |
| Q4 2020 | 5.48% |
| Q3 2020 | 211.77% |
| Q2 2020 | -71.45% |
| Q1 2020 | -5.63% |
| Q4 2019 | 30.18% |
| Q3 2019 | 18.18% |
| Q2 2019 | -15.32% |
| Q1 2019 | -6.97% |
| Q4 2018 | 37.49% |
| Q3 2018 | 53.61% |
| Q2 2018 | -29.57% |
| Q1 2018 | 48.01% |
| Q4 2017 | -14.41% |
| Q3 2017 | 33.20% |
| Q2 2017 | 143.50% |
| Q1 2017 | -47.03% |
| Q4 2016 | 71.13% |
| Q3 2016 | -43.60% |
| Q2 2016 | 43.15% |
| Q1 2016 | -28.76% |
| Q4 2015 | 27.35% |
| Q3 2015 | 81.04% |
| Q2 2015 | -40.87% |
| Q1 2015 | 6.38% |
| Q4 2014 | 157.13% |
| Q3 2014 | 99.15% |
| Q2 2014 | -70.22% |
| Q1 2014 | 27.78% |
| Q4 2013 | 59.48% |
| Q3 2013 | 722.31% |
| Q2 2013 | -110.95% |
| Q1 2013 | -6.42% |
| Q4 2012 | 28.25% |